Devin Donnelly, PharmD

ID/OPAT PharmD @ Tufts | PGY2 ID @ URMC | PGY1 @ RGH

[Contagion @Contagion_Live]

A four-week course of glecaprevir/pibrentasvir achieved sustained virologic response in 84% of patients with early hepatitis C infection in the PURGE-C trial, suggesting potential for shorter, more accessible treatment regimens pending further validation.
https://t.co/zjyYVqaXHt

[Devin Donnelly, PharmD @DevinPharmID]

@_JuliaRx Posa ppx and venetoclax 100mg. Really never see a bad LFT rise with that.

[Julia Fadul @_JuliaRx]

Polling #oncopharm what anti-fungal prophylaxis strategy does your institution utilize in AML induction (intensive and non-intensive)?

Do you avoid azoles or make dose reductions on days venetoclax is given?

Would love to hear what other centers are doing!

[Devin Donnelly, PharmD @DevinPharmID]

Honored 😎
@ashinetobacter @W_DePasquale

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕️⚡️ @AJHPOfficial
Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections #IDXposts #PWID
https://t.co/qzvqfCRz7s

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕️⚡️ @AJHPOfficial
Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections #IDXposts #PWID
https://t.co/qzvqfCRz7s

[Michael Calderwood, MD, MPH @CalderwoodMD]

Poster 625 at #SHEASpring2023: Do you have FOMO (fear of missing organisms)? If your patient with a diabetic foot infection has not had a culture with Pseudomonas in the past year, this has a negative predictive value of 94%. Hold on the pip-tazo!

[Whitney Buckel @tinymuscles]

Amoxicillin is amazing drug — don’t be afraid to push the dose to 1000 mg PO q6h- 100% target attainment for Streptococci. Check out this extremely cool paper recently published and shared by Dr. Jim Lewis at #SHEASpring2023 @SHEA_Epi https://t.co/FDC0EkMs6M

[Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship]

🚨 New Post 🚨

Here are my TOP 🔟 journal articles for infectious diseases pharmacy rotations

🤔 Have fun one not listed? Share the link and let us know why you 😁love it!
#IDtwitter #Medtwitter #TwitteRx

📲 https://t.co/B3HS1ziEqx

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕️⚡️ @antibioticsmdpi
Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of CDI
Despite higher fidaxomicin drug costs, overall cost savings were estimated at GBP 140,292 (GBP 2125 per CDI #IDTwitter
https://t.co/QKnKXRAYil

[Emma Camara @EmmaCamaraRX]

Hot take: the amount of Louis Vuitton and YSL bags I’ve seen at midyear is a blatant reminder that being here is a privilege. To the RPDs out there, please don’t discount applicants that couldn’t afford to be here with us.

[URMC Pharmacy Residency @URMCPharmRes]

Congrats to our previous PGY-2 ID residents, @ashinetobacter and @AlysaMartinRX , for the recent publication of their flipped-model research project evaluating clinical outcomes of nCP-CRE compared with carbapenem-susceptible Enterobacterales infections

https://t.co/H0yKTQpPkx

[ESBL E coli @EmpiricGame]

🙏

[Devin Donnelly, PharmD @DevinPharmID]

Got this great mug from my PGY1 co-resident today! Great start to my first week as an ID PGY2 ☕️ 💊

[Devin Donnelly, PharmD @DevinPharmID]

Officially a proud graduate of the RGH PGY1 pharmacy residency! Could not be more excited to start training in infectious diseases at URMC 🤩😎